Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine and Dexmedetomidine Combination for Analgesia After Scoliosis Surgery
NCT06062550Phase 4Active, not recruiting
- Sponsor
- Peking University First Hospital
- Start
- Oct 2023
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of esketamine in postoperative pain (3 arms), sponsored by Peking University First Hospital. Primary endpoint: Pain intensity with movement and opioid consumption at 72 hours. Started Oct 2023; status: active, not recruiting.
02
Drugs
esketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06062550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06062550.